Home / Market News / $STE
benzinga Corporate Catalyst Impact 95/100 ● positive

STERIS Inks Deal To Acquire Xodus Medical For $2.1B

Oct 12, 2026, 12:03 PM UTC · Primary ticker $STE

STERIS plc announced a definitive agreement to acquire Xodus Medical for $2.1 billion, with a net purchase price of $1.8 billion after tax benefits. This significant M&A activity is a major corporate catalyst, indicating strategic expansion and potential for revenue and earnings growth for STERIS.

STERIS plc has announced a major acquisition, agreeing to purchase Xodus Medical for $2.1 billion. This is a significant strategic move for STERIS, expanding its product portfolio in specialty surgical products and is expected to contribute approximately $245 million in annual revenue and $135 million in adjusted EBIT by 2026. The net purchase price of $1.8 billion, after accounting for $300 million in cash tax benefits, suggests a financially sound transaction. This acquisition presents a short-term opportunity for STERIS as investors react positively to growth prospects, and a long-term opportunity for increased market share and profitability. Traders should monitor STERIS's stock for upward movement due to this expansion.

$STE positive Acquisition of new business
Source: benzinga
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only.